|
|
|
|
|
|
|
20.05.26 - 06:03
|
Primer Raises $100M Series C to Bring AI to Every Payment and Accelerate US Expansion (Business Wire)
|
|
|
The round was led by Sofina with participation from Peak XV Partners and existing investors including Balderton, Accel, ICONIQ, Tencent, and Speedinvest.
The round was oversubscribed, reflecting strong investor conviction in Primer as the unified infrastructure to make merchant payments fully AI-enabled.
Funds will be used to accelerate Primer's investment in AI for payments and finance teams and to drive its expansion in the US, where it plans to grow revenue to more than a third of total revenue by 2028.
NEW YORK & SINGAPORE--(BUSINESS WIRE)--Primer today announces a $100 million Series C funding round, as it continues to build the AI-enabled operating layer for global payments and finance.
The round is led by Sofina, with participation from Peak XV Partners, and continued backing from all existing investors, including Balderton, Accel, ICONIQ, Tencent, and Speedinvest.
You can't build intelligent payments on fragmented data:
AI is only as good as the data it runs on. In payments, that data is rarely ...
|
|
|
27.03.26 - 12:24
|
Sofina FY25 Profit Declines (AFX)
|
|
|
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sofina Société Anonyme (SOF.BR) reported that its net result for fiscal 2025 was 113.00 million euros, a sharp decrease from 1.36 billion euros, previous year.......
|
|
|
18.03.26 - 13:03
|
XBOW Raises $120M to Scale its Autonomous Hacker (Business Wire)
|
|
|
Valued at over $1B, XBOW is Accelerating AI-powered Offensive Security to Help Defenders Outpace Modern AttackersSEATTLE--(BUSINESS WIRE)--XBOW, the leader in autonomous offensive security, today announced it has raised $120 million in Series C financing. The round, led by DFJ Growth and Northzone, values the company at over $1 billion.
As part of DFJ Growth's investment, Ramin Sayar, Venture Partner, will join the XBOW Board of Directors. Drawing on his experience as the former CEO of Sumo Logic, he will help the company scale operations and expand in the enterprise market. The round also includes participation from new investors Sofina and Alkeon Capital, as well as existing investors Altimeter, NFDG Ventures, and Sequoia Capital.
Until now, attackers were constrained by talent. Even the most sophisticated adversaries could not target every system, every version, all the time. With AI, that constraint is gone. Attackers now operate continuously and at scale, probing every release, every environment, an...
|
|
|
|
|
|
|
|
|
29.12.25 - 18:06
|
Azelis Group NV: Transparency Notification from First Pacific Advisors, LP. (Business Wire)
|
|
|
ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News:
In accordance with Article 14 of the Belgian Transparency law of May 2, 2007, Azelis Group NV (Brussels:AZE) announces that it has received a transparency notification from First Pacific Advisors, LP.
1. Summary of the notification
First Pacific Advisors, LP reported in its notification dated 22 December 2025, that on 16 December 2025, following a disposal of voting securities, First Pacific Advisors, LP decreased its participation and downward crossed the threshold of 10.00% in Azelis Group NV.
On 16 December 2025, First Pacific Advisors, LP owned 24,391,635 shares with voting rights, representing 9.99 % of the total number of shares issued by the company (243,921,719), versus 24,403,067 shares representing 10.00% in its previous notification dated 14 November 2025.
2. Content of the notification
Reason for the notification
Acquisition or disposal of voting securities or voting rights
Notification by
A parent undertaking or a controlling person
Persons ...
|
|
|
|
|
|
|
|
|
|
|
|
|
04.09.25 - 17:33
|
Biocodex Invests up to €30 Million in MRM Health, a Belgian Microbiome Therapy Innovator (Business Wire)
|
|
|
GENTILLY, France--(BUSINESS WIRE)--Biocodex, a French family-owned pharmaceutical pioneer in microbiota research for over 70 years, announces a strategic equity investment of €11 million in MRM Health, a Belgian clinical-stage biotech developing innovative microbiome-based therapeutics for inflammatory diseases and immune-oncology. The total partnership could reach approximately €30 million, reflecting Biocodex's long-term commitment to advancing new therapeutic approaches.
MRM Health's €55 million Series B round was led by Biocodex, with strong participation from ATHOS, new investor BNP Paribas Fortis Private Equity, and existing investors SFPIM (Belgium's sovereign wealth fund), Ackermans & van Haaren (AvH), OMX Ventures Europe (OMX), and Qbic II.
MRM Health is developing innovative treatments based on the human microbiome to address major diseases such as Inflammatory Bowel Diseases, autoimmune disorders, and certain cancers. Its lead asset, the flagship molecule MH002, has completed successfu...
|
|
|
|
|
04.09.25 - 07:06
|
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline (Business Wire)
|
|
|
Funding to support Phase 2b trial with MRM Health's lead program MH002 in ulcerative colitis and advance two additional programs to IND approval
Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing
Investment fuels expansion of proprietary CORAL® platform and pipeline
GHENT, Belgium--(BUSINESS WIRE)--#Parkinson--MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round.
The round was led by French pharmaceutical group Biocodex and included strong participation from German-based ATHOS, as well as new investor BNP Paribas Fortis Private Equity and existing investors SFPIM, Ackermans & van Haaren (AvH), OMX Europe Venture Fund (OMX), Qbic II and VIB.
Validation of Leadership Position in Microbiome-Based Therapeutics
...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
